drugset / Trial / NCT06594822
Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the effectiveness of probiotics when given in combination with standard therapy in patients of mild to moderate rheumatoid arthritis
Timeline
- Start
- 2023-08-24
- Primary completion
- 2024-01-23
- Completion
- 2024-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bacillus clausii | Other / unclassified | 5 ml | Oral |
| Comparator | Diclofenac | Other / unclassified | 50 mg | — |
| Comparator | Methotrexate | Small molecule | 10 mg | — |
| Comparator | Prednisone | Other / unclassified | 5 mg | — |
| Comparator | Sulfasalazine | Small molecule | 500 mg | — |